Outcomes of ultrasound-guided foam sclerotherapy for varicose veins of the lower extremities: A single center experience

Dermatologic Surgery

Volumn 37, Issue 6, 2011, Pages 804-809

  Hamahata, Atsumori ^a   Yamaki, Takashi ^a   Sakurai, Hiroyuki ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

POLIDOCANOL;

ADULT; AGED; ARTICLE; ECHOGRAPHY; FEMALE; FOAM; HUMAN; LEG VARICOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; SCLEROTHERAPY; TREATMENT OUTCOME; ULTRASOUND; ULTRASOUND GUIDED FOAM SCLEROTHERAPY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; RECURRENCE; RETROSPECTIVE STUDIES; SCLEROSING SOLUTIONS; SCLEROTHERAPY; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL; VARICOSE VEINS;

EID: 79959816439     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2011.02003..x     Document Type: Article

References (25)

1. Raymond-Martimbeau P. Advanced sclerotherapy treatment of varicose veins with duplex ultrasonographic guidance. Semin Dermatol 1993;12:123-8. (Pubitemid 23157663)
2. Kanter A, Thibault P. Saphenofemoral incompetence treated by ultrasound-guided sclerotherapy. Dermatol Surg 1996;22:648-52. (Pubitemid 26250696)
3. Kanter A. Clinical determinants of ultrasound-guided sclerotherapy. Part II: in search of the ideal injectate volume. Dermatol Surg 1998;24:136-8; discussion 38-40.
4. Kanter A. Clinical determinants of ultrasound-guided sclerotherapy outcome. Part I: the effects of age, gender, and vein size. Dermatol Surg 1998;24:131-5.
5. Tessari L, Cavezzi A, Frullini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg 2001;27:58-60. (Pubitemid 32107620)
6. Cabrera Garrido J, Cabrera Garcia-Olmedo J, Garcia-Olmedo Dominguez M. Elargissement des limities de la sclerotherapie: noveaux produits sclerosants. Phlebologie 1997;50:181-8.
7. Yamaki T, Nozaki M, Iwasaka S. Comparative study of duplex-guided foam sclerotherapy and duplex-guided liquid sclerotherapy for the treatment of superficial venous insufficiency. Dermatol Surg 2004;30:718-22; discussion 22.
8. Belcaro G, Cesarone MR, Di Renzo A, et al. Foam-sclerotherapy, surgery, sclerotherapy, and combined treatment for varicose veins: a 10-year, prospective, randomized, controlled, trial (VEDICO trial). Angiology 2003;54:307-15.
9. Cabrera J, Cabrera J Jr., Garcia-Olmedo MA. Sclerosants in microfoam. A new approach in angiology. Int Angiol 2001;20:322-9.
10. Frullini A, Cavezzi A. Sclerosing foam in the treatment of varicose veins and telangiectases: history and analysis of safety and complications. Dermatol Surg 2002;28:11-5. (Pubitemid 34101573)
11. Porter JM, Moneta GL. Reporting standards in venous disease: an update. International Consensus Committee on Chronic Venous Disease. J Vasc Surg 1995;21:635-45.
12. Yamaki T, Nozaki M, Sakurai H, Takeuchi M. Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations. J Vasc Surg 2008;47:578-84. (Pubitemid 351258277)
13. Hamel-Desnos C, Desnos P, Wollmann JC, Ouvry P, Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results. Dermatol Surg 2003;29:1170-5; discussion 75.
14. Rabe E, Otto J, Schliephake D, Pannier F. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial. Eur J Vasc Endovasc Surg 2008;35:238-45. (Pubitemid 351163086)
15. Barrett JM, Allen B, Ockelford A, Goldman. MP. Microfoam ultrasound-guided sclerotherapy treatment for varicose veins in a subgroup with diameters at the junction of 10mm or greater compared with a subgroup of less than 10 mm. Dermatol Surg 2004;30:1386-90. (Pubitemid 39552228)
16. Myers KA, Jolley D, Clough A, Kirwan J. Outcome of ultrasound-guided sclerotherapy for varicose veins: medium-term results assessed by ultrasound surveillance. Eur J Vasc Endovasc Surg 2007;33:116-21. (Pubitemid 44872674)
17. Ouvry P, Allaert FA, Desnos P, Hamel-Desnos C. Efficacy of polidocanol foam versus liquid in sclerotherapy of the great saphenous vein: a multicentre randomised controlled trial with a 2-year follow-up. Eur J Vasc Endovasc Surg 2008;36:366-70.
18. Hamel-Desnos C, Ouvry P, Benigni JP, Boitelle G, Comparison of 1% and 3% polidocanol foam in ultrasound guided sclerotherapy of the great saphenous vein: a randomised, double-blind trial with 2 year-follow-up. "The 3/1 Study". Eur J Vasc Endovasc Surg 2007;34:723-9; discussion 30.
19. Myers KA, Ziegenbein RW, Zeng GH, Matthews PG. Duplex ultrasonography scanning for chronic venous disease: patterns of venous reflux. J Vasc Surg 1995;21:605-12.
20. Guex JJ, Allaert FA, Gillet JL, Chleir F. Immediate and midterm complications of sclerotherapy: report of a prospective multicenter registry of 12,173 sclerotherapy sessions. Dermatol Surg 2005;31:123-8; discussion 28.
21. Guex JJ. Complications and side-effects of foam sclerotherapy. Phlebology 2009;24:270-4.
22. Forlee MV, Grouden M, Moore DJ, Shanik. G. Stroke after varicose vein foam injection sclerotherapy. J Vasc Surg 2006;43: 162-4. (Pubitemid 43083525)
23. Morrison N, Neuhardt DL, Rogers CR, McEown J, Comparisons of side effects using air and carbon dioxide foam for endovenous chemical ablation. J Vasc Surg 2008;47:830-6.
24. Smith P. Sclerotherapy and foam sclerotherapy for varicouse veins. Phlebologie 2009;24:260-9.
25. Yamaki T, Nozaki M, Sakurai H, Takeuchi M. Multiple smalldose injections can reduce the passage of sclerosant foam into deep veins during foam sclerotherapy for varicose veins. Eur J Vasc Endovasc Surg 2009;37:343-8.